Chronic Kidney Disease Registry Platform Study

Trial Identifier: D1843R00355
Sponsor: AstraZeneca
Start Date: November 2023
Primary Completion Date: August 2027
Study Completion Date: August 2027
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Changchun, China
China Changsha, China
China Chengdu, China
China Chongqing, China
China Dongwan, China
China guangzhou, China
China Guangzhou, China
China Haikou, China
China Hengyang, China
China Huaian, China
China Nanjing, China
China Nanning, China
China Ningbo, China
China Panjin, China
China Shanghai, China
China Shantou, China
China Shenzhen, China
China Taizhou, China
China Wenzhou, China
China Wuhan, China
China Wuxi, China
China Xiamen, China
China Yibin, China
China Zhuzhou, China
China Zigong, China